AU475168B2 - Anaesthetic pregnanes - Google Patents

Anaesthetic pregnanes

Info

Publication number
AU475168B2
AU475168B2 AU55284/73A AU5528473A AU475168B2 AU 475168 B2 AU475168 B2 AU 475168B2 AU 55284/73 A AU55284/73 A AU 55284/73A AU 5528473 A AU5528473 A AU 5528473A AU 475168 B2 AU475168 B2 AU 475168B2
Authority
AU
Australia
Prior art keywords
pregnanes
anaesthetic
anaesthetic pregnanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU55284/73A
Other languages
English (en)
Other versions
AU5528473A (en
Inventor
ROBIN LAWRENCE and CHRISTOPHER EARLE NEWALL GORDON HANLEY PHILLIPPS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of AU5528473A publication Critical patent/AU5528473A/en
Application granted granted Critical
Publication of AU475168B2 publication Critical patent/AU475168B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
AU55284/73A 1972-05-05 1973-05-04 Anaesthetic pregnanes Expired AU475168B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB21142/72 1972-05-05
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (2)

Publication Number Publication Date
AU5528473A AU5528473A (en) 1974-11-07
AU475168B2 true AU475168B2 (en) 1976-08-12

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55284/73A Expired AU475168B2 (en) 1972-05-05 1973-05-04 Anaesthetic pregnanes

Country Status (16)

Country Link
JP (1) JPS4961150A (en:Method)
AT (1) AT355232B (en:Method)
AU (1) AU475168B2 (en:Method)
BE (1) BE799102A (en:Method)
CA (1) CA1013341A (en:Method)
CH (1) CH617710A5 (en:Method)
DE (1) DE2322532A1 (en:Method)
ES (1) ES414411A1 (en:Method)
FR (1) FR2183792B1 (en:Method)
GB (1) GB1430942A (en:Method)
IE (1) IE37596B1 (en:Method)
IL (1) IL42196A (en:Method)
LU (1) LU67546A1 (en:Method)
NL (1) NL7306234A (en:Method)
SE (1) SE400771B (en:Method)
ZA (1) ZA733035B (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
ES2296594T3 (es) * 1994-02-14 2008-05-01 Euro-Celtique S.A. Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
CN104136452A (zh) 2011-10-14 2014-11-05 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
RU2681835C2 (ru) 2012-01-23 2019-03-13 Сейдж Терапьютикс, Инк. Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс
AU2013305767B2 (en) 2012-08-21 2018-05-24 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
LT2986624T (lt) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. Neuroaktyvūs 9-nor steroidai, skirti gydymo metodams
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
PL3498725T3 (pl) 2013-04-17 2021-11-08 Sage Therapeutics, Inc. 19-Nor C3,3-dipodstawiony C21-N-pirazolilo-steroid do zastosowania w terapii
RS61733B1 (sr) 2013-07-19 2021-05-31 Sage Therapeutics Inc Neuroaktivni steroidi, njihove kompozicije i upotrebe
WO2015027227A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
JP6893173B2 (ja) 2014-11-27 2021-06-23 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
US20200306265A1 (en) 2016-03-08 2020-10-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
ATA395173A (de) 1979-07-15
BE799102A (fr) 1973-11-05
FR2183792B1 (en:Method) 1977-07-15
GB1430942A (en) 1976-04-07
CH617710A5 (en) 1980-06-13
AT355232B (de) 1980-02-25
IL42196A (en) 1978-10-31
AU5528473A (en) 1974-11-07
JPS4961150A (en:Method) 1974-06-13
IE37596L (en) 1973-11-05
SE400771B (sv) 1978-04-10
NL7306234A (en:Method) 1973-11-07
FR2183792A1 (en:Method) 1973-12-21
ZA733035B (en) 1974-04-24
CA1013341A (en) 1977-07-05
IL42196A0 (en) 1973-07-30
DE2322532A1 (de) 1973-11-22
LU67546A1 (en:Method) 1973-07-13
IE37596B1 (en) 1977-08-31
ES414411A1 (es) 1976-02-01

Similar Documents

Publication Publication Date Title
AU475168B2 (en) Anaesthetic pregnanes
CA983342A (en) Respirator
AU474687B2 (en) Pregnane anaesthetics
AU4806372A (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
CA970706A (en) Plural-cell duct
CA996196A (en) Respirator
CA986359A (en) Projectile-case connection
CA978560A (en) Ski-bindings
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
AU466344B2 (en) Cycloalkyllactamimides
AU477138B2 (en) Anaesthetic pregnanes
AU475105B2 (en) Anaesthetic pregnanes
CA999581A (en) Triazino-benzimidazoles
CA952527A (en) Thiocarbamylsulfenamides
AU473297B2 (en) Indolylimidoylheterocyclics
CA914666A (en) Halogenated pregnanes
CA891040A (en) Humidifier
CA955989A (en) Humidifier
CA898318A (en) Humidifying means
CA895115A (en) Inhaler
AU477852B2 (en) 3-hydroxy androstanes
CA913768A (en) Ventilator
AU471575B2 (en) Novel steroids